Martín Angel· @Martin_AngelMD · X·· 23 hours agoScore70
Body
Presidential symposium 1️⃣!!
Volga trial: ph3 combo neoadjuvant EV + perioperative Durva +/- Treme. Dual primary endpoints of EFS were met. D+EV (HR 0.51) D+T+EV (HR 0.61) ❕#UrothelialCarcinoma
#ESMO26 @myESMO @tompowles1 @FAndreMD
173 views · 4 likes · 1 repost · 0 replies
Conference abstracts
LBA2matched by Presidential Symposium I
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.orgSource: Martín Angel · x.com